Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.47 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | SCN1A | P35498 | 1/20 | 0.43 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3757630 | 0.92 | MAPK1 (0.50) | LMNATDP1MAPK1ALDH1A1EGFR | |
| SCHEMBL16194376 | 0.91 | TDP1 (0.48) | LMNATDP1MAPK1HIF1AADRB2 | |
| SCHEMBL28895855 | 0.90 | EGFR (0.47) | LMNATDP1MAPK1ADRB2ADRB1 | |
| SCHEMBL8615590 | 0.90 | MAPT (0.54) | LMNATDP1MAPK1ALDH1A1EGFR | |
| SCHEMBL28895857 | 0.88 | EGFR (0.44) | LMNATDP1ADRB1ALDH1A1EGFR | |
| SCHEMBL223683 | 0.87 | LMNA (0.65) | LMNATDP1MAPK1HIF1AADRB2 | |
| SCHEMBL29358453 | 0.86 | ALDH1A1 (0.53) | LMNATDP1MAPK1ALDH1A1EGFR | |
| SCHEMBL2807375 | 0.86 | ALDH1A1 (0.53) | LMNATDP1MAPK1ALDH1A1EGFR | |
| SCHEMBL6023299 | 0.85 | SCN1A (0.55) | LMNATDP1MAPK1ADRB2ADRB1 | |
| SCHEMBL9856613 | 0.85 | LMNA (0.54) | LMNATDP1MAPK1HIF1AADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8492066-B2 | Toner compositions and processes | XEROX CORPORATION (US) | 2013-07-23 | — | — | US | claimed |
| US-20120244470-A1 | TONER COMPOSITIONS AND PROCESSES | XEROX CORPORATION (US) | 2012-09-27 | — | — | US | claimed |
| US-7736831-B2 | Emulsion/aggregation process using coalescent aid agents | XEROX CORPORATION (US) | 2010-06-15 | — | — | US | claimed |
| US-20080063965-A1 | Emulsion/aggregation processes using coalescent aid agents | XEROX CORPORATION (US) | 2008-03-13 | — | — | US | claimed |
| US-11692069-B2 | Method for making fluorocarbon free emulsions without using traditional surfactants/emulsifiers by emulsifying alkoxysilanes or other non-water soluble hydrophobizing agents using amino functional siloxanes and the uses thereof | ORGANOCLICK AB (SE) | 2023-07-04 | — | — | US | disclosed |
| CN-107282939-B | Silver nanoparticle-sulfonated polyester composite powder and preparation method thereof | 施乐公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-107286596-B | Styrene-based polymer-coated silver nanoparticle-sulfonated polyester composite powder and preparation method thereof | 施乐公司 | 2021-06-04 | — | — | CN | disclosed |
| EP-2721100-B1 | ENVIRONMENTALLY FRIENDLY COALESCING AGENTS | PTT GLOBAL CHEMICAL PUBLIC CO LTD (TH) | 2020-08-19 | — | — | EP | disclosed |
| EP-3266908-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2020-05-06 | — | — | EP | disclosed |
| CN-107287692-B | Polymer coated sulfonated polyester-silver nanoparticle composite filament and preparation method thereof | 施乐公司 | 2020-03-31 | — | — | CN | disclosed |
| CN-107287681-B | Silver polyester-sulfonated nano-particle composite filament and preparation method thereof | 施乐公司 | 2020-02-28 | — | — | CN | disclosed |
| EP-3266613-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2019-10-16 | — | — | EP | disclosed |
| US-7445790-B2 | External preparations for skin | SHISEIDO COMPANY, LTD. (JP) | 2008-11-04 | — | — | US | disclosed |
| US-7445790-B2 | External preparations for skin | SHISEIDO COMPANY, LTD. (JP) | 2008-11-04 | — | — | US | disclosed |
| US-20080063965-A1 | Emulsion/aggregation processes using coalescent aid agents | XEROX CORPORATION (US) | 2008-03-13 | — | — | US | disclosed |
| US-7323588-B2 | Isononyl benzoates and their use | OXENO OLEFINCHEMIE GMBH (DE) | 2008-01-29 | — | — | US | disclosed |
| US-20070010599-A1 | Use of isononyl benzoate as a film-forming agent | OXENO OLEFINCHEMIE GMBH (DE) | 2007-01-11 | — | — | US | disclosed |
| US-20050180931-A1 | External preparations for skin | SHISEIDO COMPANY, LTD. (JP) | 2005-08-18 | — | — | US | disclosed |
| EP-1550429-A1 | EXTERNAL PREPARATIONS FOR SKIN | SHISEIDO COMPANY, LTD. (JP) | 2005-07-06 | — | — | EP | disclosed |
| US-20040015007-A1 | Isononyl benzoates and their use | OXENO OLEFINCHEMIE GMBH (DE) | 2004-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050180931-A1 | External preparations for skin | CUTA, HRH1, CYP24A1 | LMNA 1962/4885TDP1 4101/4885MAPK1 3951/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.